Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (2,466) Arrow Down
Filter Results: (2,466) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (5,158)
    • People  (16)
    • News  (1,906)
    • Research  (2,466)
    • Events  (2)
    • Multimedia  (221)
  • Faculty Publications  (1,883)

Show Results For

  • All HBS Web  (5,158)
    • People  (16)
    • News  (1,906)
    • Research  (2,466)
    • Events  (2)
    • Multimedia  (221)
  • Faculty Publications  (1,883)
← Page 106 of 2,466 Results →
Sort by

Are you looking for?

→Search All HBS Web
  • 11 Dec 2012
  • First Look

First Look: Dec. 11

of Health Care Reform Oberholzer-Gee, Felix, Raffaella Sadun, and Richard G. HamermeshHarvard Business School Case 711-403 Per the Patient Protection and Affordable Care Act... View Details
Keywords: Sean Silverthorne
  • November 1997 (Revised May 1999)
  • Case

Medical Foods, Inc.

By: Ray A. Goldberg and Tom Clay
Dr. Franklin Lowe is CEO of a new kind of company in a new kind of industry--medical foods. He must select a business model and partners that will help make this a viable business. View Details
Keywords: Business Model; Partners and Partnerships; Business or Company Management; Strategy; Business Startups; Health Care and Treatment; Food; Innovation and Management; Health Industry; Health Industry
Citation
Educators
Purchase
Related
Goldberg, Ray A., and Tom Clay. "Medical Foods, Inc." Harvard Business School Case 598-048, November 1997. (Revised May 1999.)
  • 07 Dec 2015
  • Research & Ideas

The Rise of Personalized Entrepreneurial Finance and Other VC Trends

industries in different ways. Venture capital, for example, was once mostly reserved for institutional investors backed by endowments and pension funds. Today, it increasingly includes individual investors who are using technological tools and data to steer capital... View Details
Keywords: Re: Josh Lerner; Financial Services; Banking
  • 23 Feb 2016
  • First Look

February 23, 2016

https://www.hbs.edu/faculty/Pages/item.aspx?num=50625 February 2016 Harvard Business Review The Harvard Contest That’s Trying to Improve Health Care Delivery By: Hamermesh, Richard G., Robert S. Huckman,... View Details
Keywords: Sean Silverthorne
  • March 2010
  • Supplement

Deworming Kenya: Translating Research into Action (B)

By: Nava Ashraf, Neil Buddy Shah and Rachel Gordon
Karen Levy and her colleague, Margaret Ndanyi, learn the results of their nation-wide effort to rid Kenyan school children of parasitic worm infection. View Details
Keywords: Programs; Health Care and Treatment; Research; Policy; Outcome or Result; Kenya
Citation
Purchase
Related
Ashraf, Nava, Neil Buddy Shah, and Rachel Gordon. "Deworming Kenya: Translating Research into Action (B)." Harvard Business School Supplement 910-027, March 2010.
  • 2012
  • Working Paper

The Need for (long) Chains in Kidney Exchange

By: Itai Ashlagi, David Gamarnik, Michael A. Rees and Alvin E. Roth
It has been previously shown that for sufficiently large pools of patient-donor pairs, (almost) efficient kidney exchange can be achieved by using at most 3-way cycles, i.e., by using cycles among no more than 3 patient-donor pairs. However, as kidney exchange has... View Details
Keywords: Networks; Complexity; Performance Efficiency; Medical Specialties; Health Care and Treatment; Philanthropy and Charitable Giving
Citation
Read Now
Related
Ashlagi, Itai, David Gamarnik, Michael A. Rees, and Alvin E. Roth. "The Need for (long) Chains in Kidney Exchange." NBER Working Paper Series, No. 18202, July 2012.
  • January 2022 (Revised August 2022)
  • Case

Hello Heart: The Next Generation of Chronic Disease Management Apps

By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Health Industry; Israel; United States
Citation
Educators
Purchase
Related
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
  • March – April 2010
  • Article

Healthcare Reform and Its Implications for the U.S. Economy

By: Regina E. Herzlinger
Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; Economy; United States
Citation
Find at Harvard
Related
Herzlinger, Regina E. "Healthcare Reform and Its Implications for the U.S. Economy." Business Horizons 53, no. 2 (March–April 2010).
  • September 2024
  • Case

Myeloma Investment Fund

By: Kyle Myers and Scott Sawaya
This case explores a critical decision facing the Myeloma Investment Fund (MIF) as it evaluates two investment opportunities aimed at accelerating a cure for multiple myeloma.

The MIF, a venture philanthropy fund, must choose between two distinct paths. One... View Details
Keywords: Venture Philanthropy; Biomedical Research; Investing For Impact; Innovation & Entrepreneurship; Venture Capital; Science-Based Business; Philanthropy and Charitable Giving; Decision Making; Health Care and Treatment; Biotechnology Industry; Pharmaceutical Industry
Citation
Educators
Purchase
Related
Myers, Kyle, and Scott Sawaya. "Myeloma Investment Fund." Harvard Business School Case 625-047, September 2024.
  • August 2008 (Revised September 2008)
  • Case

The Flaxil Label (B)

This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governance; Risk and Uncertainty; Value Creation; Negotiation; Attitudes; Health Care and Treatment; Government Administration; Pharmaceutical Industry; United States
Citation
Educators
Purchase
Related
Barron, Greg M. "The Flaxil Label (B)." Harvard Business School Case 909-002, August 2008. (Revised September 2008.)
  • September 2009
  • Article

A Detailed Analysis of the Reduction Mammaplasty Learning Curve: A Statistical Process Model for Approaching Surgical Performance Improvement

By: Matthew Carty MD, Rodney Chan, Robert S. Huckman, Daniel C. Snow and Dennis Orgill

Background: The increased focus on quality and efficiency improvement within academic surgery has met with variable success among plastic surgeons. Traditional surgical performance metrics, such as morbidity and mortality, are insufficient to improve the... View Details

Keywords: Experience and Expertise; Health Care and Treatment; Medical Specialties; Outcome or Result; Performance Efficiency; Performance Improvement
Citation
Find at Harvard
Related
Carty, Matthew, MD, Rodney Chan, Robert S. Huckman, Daniel C. Snow, and Dennis Orgill. "A Detailed Analysis of the Reduction Mammaplasty Learning Curve: A Statistical Process Model for Approaching Surgical Performance Improvement." Plastic and Reconstructive Surgery 124, no. 3 (September 2009): 706–714.
  • 13 Oct 2010
  • Research & Ideas

How Government can Discourage Private Sector Reliance on Short-Term Debt

the implications of our findings, which is to say that the government could actively influence the corporate sector's borrowing decisions by shifting its own financing between T-bills and bonds. Why should we care about how the private... View Details
Keywords: by Staff; Financial Services
  • 11 Nov 2014
  • First Look

First Look: November 11

2014 and again in 2015. Publisher's link: http://hbr.org/2014/11/digital-ubiquity-how-connections-sensors-and-data-are-revolutionizing-business/ar/1 November 2014 Harvard Business Review How Not to Cut Health View Details
Keywords: Sean Silverthorne
  • 01 Dec 2003
  • What Do You Think?

Is This the Twilight Era for the Managed Mutual Fund?

a vile 'market timer' is a sad commentary on how inflexibly the mutual fund industry is viewed by academics, regulators and distributors." Richard Eckel suggests that both perceptions and real problems will be addressed when, among... View Details
Keywords: by James Heskett
  • 03 Mar 2015
  • First Look

First Look: March 3

Abstract—Improving the way we pay for health care must be a central component in health care reform. Payment reform must link provider... View Details
Keywords: Sean Silverthorne
  • January 2023 (Revised September 2024)
  • Supplement

The END Fund (B)

By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details
Keywords: Health Disorders; Investment Funds; Global Range; Nonprofit Organizations; Resource Allocation; Decisions; Health Care and Treatment; Mission and Purpose
Citation
Purchase
Related
Rangan, V. Kasturi, and Courtney Han. "The END Fund (B)." Harvard Business School Supplement 523-064, January 2023. (Revised September 2024.)
  • 02 May 2008
  • What Do You Think?

What is the Future of State Capitalism?

the World Trade Organization. C. J. Cullinane comments, "We need ... global guidelines and regulations as well as transparency." Jacoline Loewen, concurs, saying that "there may not be global rules for State Capitalism yet,... View Details
Keywords: by Jim Heskett
  • 01 Dec 2003
  • Research & Ideas

Sometimes Success Begins at Failure

in history. Most firms act as if false negatives don't exist because they don't have processes for managing them. In their own industries, many companies might have missed similar opportunities. Although smart organizations have traditionally taken View Details
Keywords: by Henry Chesbrough; Health; Health
  • 11 Mar 2008
  • First Look

First Look: March 11, 2008

http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=808104 Partners in Health: The PACT Project Harvard Business School Case 608-065 Partners in Health (PIH) is a Boston-based, not-for-profit that provides View Details
Keywords: Martha Lagace
  • January 2009
  • Teaching Note

Biocon: Launching a New Cancer Drug in India (TN)

By: Sunil Gupta and Das Narayandas
Teaching Note for [508026]. View Details
Keywords: Product Launch; Market Timing; Price; Distribution Channels; Marketing Strategy; Health Care and Treatment; Biotechnology Industry; Pharmaceutical Industry; India
Citation
Purchase
Related
Gupta, Sunil, and Das Narayandas. "Biocon: Launching a New Cancer Drug in India (TN)." Harvard Business School Teaching Note 509-039, January 2009.
  • ←
  • 106
  • 107
  • …
  • 123
  • 124
  • →

Are you looking for?

→Search All HBS Web
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.